AEYE Health
About AEYE Health
AEYE Health is a digital health company specializing in FDA-cleared, autonomous AI-based diagnostic screening solutions for retinal imaging. Their flagship product, AEYE-DS, enables healthcare providers, including primary care physicians and endocrinologists, to perform on-the-spot screenings for more-than-mild diabetic retinopathy (DR) in adults with diabetes. This eliminates the traditional need for immediate specialist referrals, making critical sight-saving screenings more accessible, especially in underserved areas. The screening process is efficient, typically taking one minute with a single image per eye, and can be conducted using portable handheld or robotic tabletop cameras, often without pupil dilation.
The AEYE-DS system is designed to seamlessly integrate into existing clinical workflows, providing instant diagnostic reports and supporting improved HEDIS scores and patient outcomes. It is reimbursable under CPT code 92229, offering a practical and financially viable solution for point-of-care screening. Beyond diabetic retinopathy, AEYE Health is actively expanding its comprehensive screening platform to diagnose and predict a broader spectrum of ocular diseases, such as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), occlusions, hypertensive retinopathy, and papilledema. The company is also developing capabilities to detect systemic conditions like hypertension, cardiovascular risk, and dementia from retinal images, aiming for early intervention and prevention of serious health issues.
Focus Areas
Business Intelligence
| Key Investors | BioLight Life Sciences, OurCrowd, Ambit Health Ventures, SK Group Israel, Sean Ianchulev (Angel), Club 100 Plus, Naska Medical |
| Partnerships | Ford Medical, UMass Medical School, UMass Memorial Health Care, IRIS (Intelligent Retinal Imaging Systems), Topcon Healthcare, Epic EMR |
| Acquisitions | None |
| Technology | Cloud-native, fully autonomous AI-based diagnostic screening solution for retinal imaging, utilizing machine learning algorithms for instant, on-the-spot analysis. Designed for use with both portable handheld and robotic tabletop cameras, requiring only one image per eye and often no dilation. Integrates with Electronic Medical Record (EMR) systems like Epic. |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
AEYE Health's solutions offer significant advantages for physicians, particularly in primary care. The autonomous AI for diabetic retinopathy (AEYE-DS) allows for rapid, accurate, and reimbursable point-of-care screening, reducing the administrative burden and eliminating the need for immediate specialist referrals for initial diagnosis. This streamlines clinical workflows, improves HEDIS scores, and enhances patient adherence to critical screenings, leading to earlier detection and intervention for DR. The ability to provide immediate results and discuss them with patients during the same visit fosters better patient education and engagement. For broader disease detection, their investigational AEYE-CS platform aims to provide early insights into a range of ocular and systemic conditions, potentially enabling proactive management and improved patient outcomes across multiple health domains.
AEYE Health's AEYE-DS features seamless integration with major electronic medical/health record (EMR/EHR) systems, including Epic. This integration allows healthcare providers to order diabetic retinopathy screenings directly from the patient's chart, and the AI diagnostic results and reports are automatically returned to the EMR within seconds. The system can also trigger automated referrals to ophthalmology if referable disease is detected, further streamlining care coordination and reducing manual data entry.
Reviews & Opinions
Videos
News, demos, and interviews about AEYE Health.
Videos load interactively. If none appear, search YouTube for AEYE Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded AEYE Health.
Related Companies
Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]